Tevogen Bio CEO reinforces commitment to retention of equity capitalon February 17, 2025 at 8:28 am MAK Gojar 1 year ago Post Content Post Content Share this: Alkemy Capital secures £1.035 million in oversubscribed placingon February 17, 2025 at 7:08 amDateFebruary 17, 2025In relation toMarkets NewsJapan GDP grows much more than expected in Q4 on exports, capital spendingon February 17, 2025 at 12:00 amDateFebruary 17, 2025In relation toMarkets NewsTonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conferenceon February 5, 2025 at 12:16 pmDateFebruary 5, 2025In relation toMarkets News
